Literature DB >> 24265572

Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake?

Cornelia Bettina Brendle1, Philip Aschoff, Thomas Kratt, Christina Schraml, Matthias Reimold, Claus Detlef Claussen, Christina Anna Pfannenberg.   

Abstract

OBJECTIVE: Suspicious incidental gastrointestinal FDG uptake during positron-emission tomography/computed tomography (PET/CT) examinations can be caused by different diseases, including malignancies. However, differentiation with PET alone is difficult. The aim of this study was to investigate the potential of PET alone, contrast-enhanced CT (ceCT), and low-dose CT (ldCT) in routine PET/CT protocols for differentiation of incidental gastrointestinal lesions.
MATERIALS AND METHODS: Sixty patients with incidental gastrointestinal lesions who underwent a routine PET/CT protocol with ldCT and ceCT were retrospectively analysed. The PET lesions were evaluated regarding their FDG uptake patterns and the standard uptake value. The anatomical correlates in both CT protocols were compared in regard to the correct lesion classification with the reference standard endoscopy.
RESULTS: Sixty-two lesions were found in 60 patients (17 malignant, 10 premalignant, 5 benign, 13 inflammatory, 17 physiological). The differentiation of the FDG uptake patterns did not enable reliable lesion classification. The positive predictive value for pathology was 0.81 for ceCT in PET/CT and 0.70 for ldCT. Malignancies were detected in 100% of the patients by ceCT vs. 29.4% by ldCT. The false negative rate of ceCT for all pathologies was 31.1%, vs. 68.9% for ldCT. False positive results (17/62) could not be excluded sufficiently by either CT protocol.
CONCLUSION: PET/ceCT protocols provide additional benefit especially in detecting gastrointestinal malignancies as a cause of suspicious incidental gastrointestinal FDG uptake. However, since follow-up endoscopy cannot be forgone due to the considerable false negative rate even with ceCT, the addition of ceCT to a routine PET/ldCT protocol cannot be recommended for this purpose.

Entities:  

Keywords:  CT; Gastrointestinal lesions; Incidental FDG uptake; PET; PET/CT

Mesh:

Substances:

Year:  2013        PMID: 24265572      PMCID: PMC3835644          DOI: 10.3348/kjr.2013.14.6.951

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


  18 in total

1.  PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance.

Authors:  Ora Israel; Nikolay Yefremov; Rachel Bar-Shalom; Olga Kagana; Alex Frenkel; Zohar Keidar; Doron Fischer
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

2.  18F-FDG PET detection of colonic adenomas.

Authors:  S Yasuda; H Fujii; T Nakahara; N Nishiumi; W Takahashi; M Ide; A Shohtsu
Journal:  J Nucl Med       Date:  2001-07       Impact factor: 10.057

3.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Authors:  H Engel; H Steinert; A Buck; T Berthold; R A Huch Böni; G K von Schulthess
Journal:  J Nucl Med       Date:  1996-03       Impact factor: 10.057

Review 4.  Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma.

Authors:  D Delbeke
Journal:  J Nucl Med       Date:  1999-04       Impact factor: 10.057

Review 5.  Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.

Authors:  L G Strauss
Journal:  Eur J Nucl Med       Date:  1996-10

6.  Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.

Authors:  H Abdel-Nabi; R J Doerr; D M Lamonica; V R Cronin; P J Galantowicz; G M Carbone; M B Spaulding
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

7.  Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT: correlation with endoscopic and histopathologic results.

Authors:  Ehab M Kamel; Miriam Thumshirn; Kaspar Truninger; Marc Schiesser; Michael Fried; Barbara Padberg; Didier Schneiter; Sandro J Stoeckli; Gustav K von Schulthess; Katrin D M Stumpe
Journal:  J Nucl Med       Date:  2004-11       Impact factor: 10.057

8.  Detection of unexpected additional primary malignancies with PET/CT.

Authors:  Takayoshi Ishimori; Pavni V Patel; Richard L Wahl
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

9.  Incidental finding of focal FDG uptake in the bowel during PET/CT: CT features and correlation with histopathologic results.

Authors:  Pin Lin Kei; Raghunandan Vikram; Henry W D Yeung; John R Stroehlein; Homer A Macapinlac
Journal:  AJR Am J Roentgenol       Date:  2010-05       Impact factor: 3.959

10.  Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings.

Authors:  Rozet Tatlidil; Hossein Jadvar; James R Bading; Peter S Conti
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

View more
  1 in total

1.  Contrast-enhanced [18F] fluorodeoxyglucose-positron emission tomography-computed tomography as an initial imaging modality in patients presenting with metastatic malignancy of undefined primary origin.

Authors:  Avani Jain; Madhur Kumar Srivastava; Alok Suresh Pawaskar; Simon Shelley; Indirani Elangovan; Hasmukh Jain; Somnath Pandey; Shilpa Kalal; Jaykanth Amalachandran
Journal:  Indian J Nucl Med       Date:  2015 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.